DXP Enterprises, Inc. Completes Acquisition of Alliance Pump & Mechanical Service, Inc.
HOUSTON–(BUSINESS WIRE)–DXP Enterprises, Inc. (NASDAQ: DXPE) today announced the completion of the acquisition of Alliance Pump & Mechanical Service,... Read more.
Global Market for Telecommunications Services Has Accelerated Again, Fueled by Inflation, But Not in All Regions, According to IDC
NEEDHAM, Mass.–(BUSINESS WIRE)–#Broadband–Worldwide spending on telecommunication and pay TV services will reach $1.55 trillion in 2023, an increase... Read more.
AM Best Affirms Credit Ratings of Ameriprise Financial, Inc. and Its Subsidiaries
OLDWICK, N.J.–(BUSINESS WIRE)–#insurance—AM Best has affirmed the Financial Strength Rating (FSR) of A+ (Superior) and the Long-Term Issuer Credit... Read more.
Clinical Consensus on Kerecis Fish-Skin Grafts to be Presented at the SAWC Wound Conference
Consensus symposium and multiple poster abstracts demonstrate efficacy of fish-skin grafts in wound treatment and reconstructive surgery LAS VEGAS–(BUSINESS... Read more.
AM Best Affirms Credit Ratings of ICM Assurance Ltd
OLDWICK, N.J.–(BUSINESS WIRE)–#insurance—AM Best has affirmed the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Rating... Read more.
Global mRNA Vaccine Market Research Report 2023: On-going Clinical Trials, Drug Pipeline, Mergers & Acquisitions, & Product Launches – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “mRNA Vaccine Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By mRNA Type,... Read more.
AbCellera Presents New Data on Two T-Cell Engager Programs at SITC 2023
New data from AbCellera’s T-cell engager platform demonstrates that diverse CD3-binding antibodies enable optimization of T-cell engager function beyond what is... Read more.
Xencor Presents Preclinical Data from Multiple XmAb® Research Programs at the SITC Annual Meeting
PASADENA, Calif.–(BUSINESS WIRE)–Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines... Read more.
New Phase 1 Dose Escalation Data Show Well-Tolerated Safety Profile and Anti-Tumor Activity for Aulos Bioscience’s AU-007 at Society for Immunotherapy of Cancer (SITC) Annual Meeting
Preliminary evidence of anti-tumor activity observed in heavily pre-treated patients, including those whose tumors progressed through checkpoint inhibitors Further... Read more.
TriSalus Life Sciences Presents Data for SD-101 Delivered by TriSalus Infusion System for Pancreatic Adenocarcinoma at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
– New data from PERIO-03 clinical trial indicates PEDD™ method resulted in modulation of the tumor microenvironment by enabling performance of a TLR9 agonist... Read more.